Cargando…
Cebranopadol: A First-in-Class Nociceptin Receptor Agonist for Managing Chronic Pain
Autores principales: | Nair, Abhijit S, Mantha, Shyam Prasad, Pulipaka, Sai Kaushik, Rayani, Basanth Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017681/ https://www.ncbi.nlm.nih.gov/pubmed/32132804 http://dx.doi.org/10.4103/IJPC.IJPC_117_19 |
Ejemplares similares
-
Role of almitrine bismesylate in managing refractory hypoxemia in COVID19 acute respiratory distress syndrome
por: Nair, Abhijit S., et al.
Publicado: (2021) -
Lidocaine 5% Patch in Localized Neuropathic Pain
por: Nair, Abhijit S, et al.
Publicado: (2019) -
Sublingual Buprenorphine: A Feasible Alternative for Treating Breakthrough Chronic Pain
por: Nair, Abhijit S, et al.
Publicado: (2019) -
Unusual path taken by peripherally inserted central catheter guidewire
por: Mantha, Srinivasa S. P., et al.
Publicado: (2019) -
Levorphanol: Rewinding an Old, Bygone Multimodal Opioid Analgesic!
por: Nair, Abhijit S, et al.
Publicado: (2019)